✦ LIBER ✦

One year open-label safety and efficacy trial with rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome

✍ Scribed by Wolfgang H. Oertel; Heike Benes; Diego Garcia-Borreguero; Peter Geisler; Birgit Högl; Claudia Trenkwalder; Ingrid Tacken; Erwin Schollmayer; Ralf Kohnen; Karin Stiasny-Kolster

Book ID: 116884569
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 206 KB
Volume: 9
Category: Article
ISSN: 1389-9457
DOI: 10.1016/j.sleep.2008.04.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term safety and efficacy of rotigot

Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study

✍ Wolfgang Oertel; Claudia Trenkwalder; Heike Beneš; Luigi Ferini-Strambi; Birgit 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 391 KB

Treatment of moderate to severe restless

Treatment of moderate to severe restless legs syndrome: 2-year safety and efficacy of rotigotine transdermal patch

✍ Birgit Högl; Wolfgang H Oertel; Karin Stiasny-Kolster; Peter Geisler; Heike Bene 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 552 KB

O0027 Rotigotine transdermal patch provi

O0027 Rotigotine transdermal patch provides continuous efficacy in patients with moderate to severe idiopathic restless legs syndrome – 24 month results from a multi-national, multi-centre, open-label, follow-up trial

✍ C. Trenkwalder; K. Stiasny-Kolster; W. Poewe; E. Schollmayer; W.H. Oertel 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 49 KB

W-L-104 SLEEP IMPROVEMENTWITH ROTIGOTINE

W-L-104 SLEEP IMPROVEMENTWITH ROTIGOTINE TRANSDERMAL SYSTEM IN PATIENTS WITH MODERATE-TO-SEVERE IDIOPATHIC RESTLESS LEGS SYNDROME (RLS): RESULTS FROM TWO 6-MONTH PLACEBO-CONTROLLED TRIALS

✍ Art Walters; Richard Bogan; William Ondo; Richard Allen; Markku Partinen; Erwin 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 66 KB